To identify the efficacy of certolizumab pegol (CZP) on synovitis in dynamic MRI parameters; to make the correlation between European League Against Rheumatism (EULAR), American College of Rheumatology (ACR)p, Disease Activity Score-28 (DAS 28) responses, and Digital XRay (DXR) assessment with reduction of synovitis.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01235598?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
